AN2 Therapeutics Inc
NASDAQ:ANTX
Income Statement
Earnings Waterfall
AN2 Therapeutics Inc
Income Statement
AN2 Therapeutics Inc
| Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(42)
|
(51)
|
(57)
|
(63)
|
(70)
|
(72)
|
(71)
|
(65)
|
(55)
|
(50)
|
(41)
|
(37)
|
|
| Selling, General & Administrative |
(13)
|
(15)
|
(14)
|
(15)
|
(15)
|
(14)
|
(15)
|
(15)
|
(14)
|
(14)
|
(15)
|
(14)
|
|
| Research & Development |
(30)
|
(36)
|
(43)
|
(49)
|
(55)
|
(58)
|
(56)
|
(50)
|
(40)
|
(34)
|
(25)
|
(23)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
|
| Operating Income |
(42)
N/A
|
(51)
-20%
|
(57)
-12%
|
(63)
-11%
|
(70)
-10%
|
(72)
-3%
|
(71)
+1%
|
(65)
+9%
|
(55)
+16%
|
(50)
+8%
|
(41)
+17%
|
(37)
+10%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
1
|
2
|
3
|
4
|
0
|
4
|
5
|
4
|
5
|
5
|
4
|
3
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(41)
N/A
|
(49)
-19%
|
(54)
-12%
|
(60)
-10%
|
(65)
-8%
|
(66)
-2%
|
(65)
+2%
|
(61)
+6%
|
(51)
+16%
|
(46)
+11%
|
(38)
+17%
|
(34)
+10%
|
|
| Net Income | |||||||||||||
| Income from Continuing Operations |
(41)
|
(49)
|
(54)
|
(60)
|
(65)
|
(66)
|
(65)
|
(61)
|
(51)
|
(46)
|
(38)
|
(34)
|
|
| Net Income (Common) |
(43)
N/A
|
(49)
-14%
|
(54)
-12%
|
(60)
-10%
|
(65)
-8%
|
(66)
-2%
|
(65)
+2%
|
(61)
+6%
|
(51)
+16%
|
(46)
+11%
|
(38)
+17%
|
(34)
+10%
|
|
| EPS (Diluted) |
-2.79
N/A
|
-2.52
+10%
|
-2.8
-11%
|
-2.32
+17%
|
-2.74
-18%
|
-2.21
+19%
|
-2.16
+2%
|
-2.04
+6%
|
-1.72
+16%
|
-1.52
+12%
|
-1.25
+18%
|
-1.13
+10%
|
|